Dosing IV Iron Based on Ferritin Levels

Introduction to IV Iron Dosing

The American Gastroenterological Association recommends that for inflammatory bowel disease patients, the following table based on hemoglobin and weight be used to determine the IV iron dose:
The National Kidney Foundation suggests that in dialysis patients, IV iron should be initiated or continued when ferritin is <100 ng/mL and transferrin saturation is <20%, though treatment may continue with ferritin up to 500 ng/mL if functional iron deficiency exists 4, 5

The European Crohn’s and Colitis Organisation recommends that for patients with iron deficiency anemia, the total IV iron dose should be calculated based on hemoglobin level and body weight rather than ferritin alone, with dosing guided by the following table for inflammatory bowel disease patients 1, 2
The American Society of Nephrology states that ferritin guides the decision to treat, not the dose, with ferritin <45 ng/mL in non-inflammatory conditions confirming iron deficiency and warranting treatment 3

The American College of Gastroenterology recommends that ferritin <100 ng/mL in inflammatory conditions (IBD, CKD, chronic disease) indicates iron deficiency 3, 1, 2
The Kidney Disease: Improving Global Outcomes (KDIGO) guidelines suggest that in dialysis patients, ferritin <100 ng/mL and transferrin saturation <20% indicate iron deficiency, with treatment continuing up to ferritin 500 ng/mL if functional iron deficiency exists 4, 5

The American Journal of Kidney Diseases states that general population should avoid chronic maintenance of ferritin >800 ng/mL 4
The European Renal Association - European Dialysis and Transplant Association recommends that dialysis patients target ferritin 250-500 ng/mL, not exceeding 500 ng/mL chronically 6, 4

The Clinical Nutrition journal suggests that IV iron should be prioritized as first-line in scenarios with hemoglobin <10 g/dL, clinically active IBD, previous intolerance to oral iron, or need for erythropoiesis-stimulating agents 1, 2
The Journal of Crohn's and Colitis recommends attempting oral iron first in patients with mild anemia, clinically inactive disease, and no prior oral iron intolerance 1, 2

The Journal of Crohn's and Colitis states that IBD patients should be monitored every 3 months for the first year after correction, then every 6-12 months thereafter 2
The Clinical Nutrition journal recommends reinitiating IV iron when ferritin drops below 100 ng/mL or hemoglobin falls below 12 g/dL (women) or 13 g/dL (men) in previously treated patients 1, 2

The Drugs journal suggests choosing high-dose formulations that allow complete repletion in 1-2 infusions, such as ferric carboxymaltose (Injectafer), iron isomaltoside, and ferric derisomaltose 6
The American Journal of Kidney Diseases recommends avoiding iron dextran as first-line due to higher anaphylaxis risk compared to newer formulations 8

The Clinical Gastroenterology and Hepatology journal warns against withholding IV iron based solely on elevated ferritin in inflammatory conditions, as inflammation artificially raises ferritin; use transferrin saturation <20% to identify functional iron deficiency 3, 4, 2
The Blood journal advises against underdosing, as studies show patients frequently receive less iron than their calculated need, resulting in persistent anemia in >65% of cases 7